Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pila Pharma
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
28 Aug 2023
Initiation of coverage Nosa Plugs: Smelling success, plugging a hole in the market
Equity Research
Nosa Plugs
25 Aug 2023
Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
Equity Research
24 Aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research
Observit
23 Aug 2023
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
Equity Research
23 Aug 2023
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
Equity Research
23 Aug 2023
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
Equity Research
Carlsquare
22 Aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research
Observit
22 Aug 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research
Kancera
21 Aug 2023
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
Equity Research
InCoax
18 Aug 2023
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
Equity Research
18 Aug 2023
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
Equity Research
InCoax
18 Aug 2023
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
Equity Research
Risk Intelligence
17 Aug 2023
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
Equity Research
16 Aug 2023
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
Equity Research
Biosergen
16 Aug 2023
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
Equity Research
Risk Intelligence
16 Aug 2023
Carlsquare weekly market letter: The market breaks downwards
Equity Research
Carlsquare
14 Aug 2023
Research Update H&D Wireless, Q2 2023: Good order intake, but not yet break-even
Equity Research
11 Aug 2023
Video Interview H&D Wireless
Equity Research
11 Aug 2023
First Impression H&D Wireless, Q2 2023: Improved order intake
Equity Research
09 Aug 2023
Carlsquare weekly market letter: Oil and inflation stir emotions
Equity Research
Carlsquare
1
…
21
22
23
24
25
…
64